華體科技(603679.SH):首發募投項目結項 節餘資金永久補充流動資金
格隆匯12月29日丨華體科技(603679.SH)公佈,公司首發募投項目已按計劃實施完畢,由於“城市照明系統技術改造及擴產”項目另有應付未付設備尾款454.05萬元尚未支付,扣除應付未付設備尾款後實際節餘募集資金5966.84萬元。
為提高募集資金使用效率,維護公司及全體股東利益,公司擬將首發募投項目結項後的節餘募集資金5966.84萬元全部用於永久補充流動資金(實際金額以轉入自有資金賬户當日募集資金專户餘額為準)。本次擬永久補充流動資金的金額佔首發募投項目募集資金淨額的28.96%,尚需提交公司股東大會審議批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.